BioTelemetry, Inc.
(NASDAQ GS: BEAT)
Rigrodsky Law, P.A. is investigating BioTelemetry, Inc. (“BioTelemetry”) regarding possible breaches of fiduciary duties and other violations of law related to BioTelemetry’s agreement to be acquired by Royal Philips. Under the terms of the agreement, BioTelemetry’s shareholders will receive $72.00 in cash per share.